STOCK TITAN

Lifeward (LFWD) awards 11,485 RSUs to company director

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Rozenbaum Moshe H reported acquisition or exercise transactions in this Form 4 filing.

Lifeward Ltd. director Moshe H Rozenbaum reported an equity compensation grant of 11,485 ordinary shares in the form of restricted stock units (RSUs). The award was granted on March 25, 2026 under the company’s 2025 Incentive Compensation Plan at a grant price of $0.0000 per share.

The 11,485 RSUs vest ratably in four equal quarterly installments starting three months from the grant date, meaning the director earns the shares over time rather than all at once. After this grant, Rozenbaum’s reported direct holdings total 11,485 ordinary shares.

Positive

  • None.

Negative

  • None.
Insider Rozenbaum Moshe H
Role Director
Type Security Shares Price Value
Grant/Award Ordinary Shares, no par value per share 11,485 $0.00 --
Holdings After Transaction: Ordinary Shares, no par value per share — 11,485 shares (Direct)
Footnotes (1)
  1. [object Object]
RSU grant size 11,485 shares Ordinary shares via RSUs granted on March 25, 2026
Grant price per share $0.0000 per share Equity compensation, not an open-market purchase
Vesting installments 4 equal quarterly installments RSUs vest ratably starting three months from grant date
Shares owned after transaction 11,485 shares Total ordinary shares reported following the grant
Grant date March 25, 2026 Date RSUs were granted under 2025 Incentive Compensation Plan
restricted stock units ("RSUs") financial
"issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2025 Incentive Compensation Plan financial
"RSUs granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan"
vest ratably financial
"The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rozenbaum Moshe H

(Last)(First)(Middle)
C/O LIFEWARD LTD.
2 CABOT RD.

(Street)
HUDSON MASSACHUSETTS 01749

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares, no par value per share03/25/2026A11,485(1)A$0.0011,485D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents 11,485 ordinary shares, no par value per share, issuable upon the vesting of restricted stock units ("RSUs") granted on March 25, 2026 (the "Grant Date") under the Issuer's 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months from the Grant Date.
/s/ Almog Adar, as Attorney-in-Fact04/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Lifeward (LFWD) director Moshe H Rozenbaum report in this Form 4?

He reported receiving a grant of 11,485 restricted stock units (RSUs). The award represents ordinary shares under Lifeward’s 2025 Incentive Compensation Plan and is a form of equity compensation rather than an open-market stock purchase.

How many Lifeward (LFWD) shares are covered by the new RSU grant?

The grant covers 11,485 ordinary shares through RSUs. These units convert into shares as they vest over time, giving the director potential ownership that is tied to continued service and the vesting schedule.

When do the Lifeward (LFWD) RSUs granted to the director begin vesting?

The RSUs begin vesting three months after March 25, 2026. Vesting then continues in four equal quarterly installments, so the director earns one-quarter of the 11,485 units at each quarterly vesting date.

What is the vesting schedule for the 11,485 Lifeward (LFWD) RSUs?

The 11,485 RSUs vest ratably in four equal quarterly installments. Starting three months from the March 25, 2026 grant date, one-quarter of the units vests each quarter until the full award has vested.

Did the Lifeward (LFWD) director pay cash for these 11,485 shares?

No, the Form 4 shows a transaction price of $0.0000 per share. This indicates the shares were granted as equity compensation, not purchased in the open market for cash consideration.

How many Lifeward (LFWD) shares does the director report owning after this grant?

After the grant, the director reports direct ownership of 11,485 ordinary shares. This figure reflects the total shares reported following the transaction in the Form 4 filing.